Conference Coverage

VIDEO: Unraveling Alzheimer’s pathogenesis while testing lifestyle interventions


 

EXPERT ANALYSIS FROM THE ADRD SUMMIT 2016

References

BETHESDA, MD. – Alzheimer’s disease is not the failure of a single type of cell – or even a single physiologic system, so while the search for effective treatments goes on, basic research must continue to unravel many of its fundamental mechanisms, according to Dr. Ronald Petersen, director of the Mayo Clinic Alzheimer’s Disease Research Center in Rochester, Minn.

But in lieu of available treatments that target the underlying pathology of Alzheimer’s, trials must continue to test lifestyle interventions with diet and exercise that in preliminary studies have started proving their worth in decreasing the risk of cognitive decline or delaying its onset.

Dr. Petersen discussed these issues in an interview at the Alzheimer’s Disease–Related Dementias 2016 Summit, sponsored by the National Institutes of Health.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

msullivan@frontlinemedcom.com

On Twitter @alz_gal

Recommended Reading

In vivo tau imaging correlated with Braak stages in older adults
MDedge Psychiatry
AD patients start antidepressants before diagnosis
MDedge Psychiatry
VIDEO: How to navigate value-based care payer contracts
MDedge Psychiatry
Antidepressants tied to lower dementia mortality
MDedge Psychiatry
Drug interaction myths
MDedge Psychiatry
Higher levels of function before hip fracture tied to greater fears of falling at 1 year
MDedge Psychiatry
Chaplains play important part of integrated palliative care
MDedge Psychiatry
Parkinson’s disease psychosis drug gets favorable review from FDA advisory panel
MDedge Psychiatry
Parkinson’s disease psychosis drug gets favorable review from FDA advisory panel
MDedge Psychiatry
Prepsychosis links with elevated metabolic syndrome
MDedge Psychiatry